skip to main content
Research Policy and Compliance  /  Committees  /  Administrative Committee on Biosafety  /  Institutional Biosafety Committee (IBC)

Institutional Biosafety Committee (IBC)

The Institutional Biosafety Committee (IBC) is charged with reviewing protocols for research and teaching that involve the use of recombinant DNA (rDNA) subject to the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines), infectious biological agents, and biohazardous agents at Caltech. Committee oversight helps to ensure that all research protocols involving biohazardous materials and the facilities used to conduct the research are in compliance with existing government regulations and applicable Caltech policies.

The IBC membership is constituted in accordance with the NIH Guidelines and the IBC meets monthly to review protocols proposing use of recombinant DNA and biohazards.

The IBC works in conjunction with the Institute Animal Care and Use Committee, the Institutional Review Board, the Human Embryos and Stem Cells Committee, and radiation safety.

The Institutional Biosafety Committee meets the 1st Tuesday of the month, as necessary. A meeting may be canceled if there are no protocols for review.

All protocols must be submitted at least three weeks prior to the meeting date in order to be considered at that meeting. Please contact for more details.

Upcoming meetings:

January 16, 2024

February 6, 2024

March 5, 2024

April 2, 2024

May 7, 2024

June 4, 2024

July 2, 2024

August 6, 2024

September 3, 2024

October 1, 2024

November 5, 2024

December 3, 2024

IBC Administrator

(626) 395-6435

Institute Biosafety Officer

Lauriane Quenee

Committee Chair

Rustem Ismagilov